Romy Seth

Romy Seth has a diverse range of work experience in various industries. In 2011, they worked as a Chemical Engineer in the Space Biosciences Division at NASA's Ames Research Center, conducting biological research and technology development for NASA's exploration mission. From 2012 to 2014, Romy worked as an Analyst at Prism Capital, a private equity firm, providing subordinated debt and expansion capital to companies. Following that, from 2014 to 2019, they held the role of Vice President at Ferghana Partners. In 2020, Romy co-founded iPill Dispenser, and in 2019, became a Founding Partner at Tungsten Advisors, an investment banking firm specializing in healthcare and technology companies. Most recently, in 2022, Romy joined the Cancer Prevention and Research Institute of Texas (CPRIT) as a Scientist Reviewer, investing in innovative cancer research and prevention efforts in Texas.

Romy Seth has a Double Degree from the University of Toronto, consisting of a BASc in Chemical Engineering with a minor in Bioengineering, and a BSc in Human Biology and Toxicology. There is no information provided regarding the start and end years of this education. Furthermore, Romy Seth has obtained additional certifications including the Securities Industry Essentials, Series 63, and Series 79 (Investment Banking Representative), from FINRA. The specific details such as the months and years of obtaining these certifications have not been provided.